Feedback from stakeholders by theme for the consultation on the revised fee proposal for drugs and medical devices

The table below lists feedback we received for the consultation on the revised fee proposal for drugs and medical devices. The feedback is available to members of the public upon request, for the sole purpose of ensuring greater transparency. To request a copy send your request by email, citing the submission number, to: HC.CRO-BRC.SC@canada.ca

Submission number Stakeholder Name Association / Company Product Theme
1 Sandra Gordey Alberta Health Services Radiopharmaceutical Drug Mitigation Measures
2 Tina Roy Allergan Inc Pharmaceuticals (Innovator/Biologic Drugs Annual Fee Adjustment
3 Tina Roy Allergan Inc Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
4 Caroline Piché Association pour le Développement et l'Innovation en Chimie au Québec (ADICQ) Disinfectants Fee Setting
5 Caroline Piché Association pour le Développement et l'Innovation en Chimie au Québec (ADICQ) Disinfectants Fee Setting
6 Caroline Piché Association pour le Développement et l'Innovation en Chimie au Québec (ADICQ) Disinfectants Fee Setting
7 Caroline Piché Association pour le Développement et l'Innovation en Chimie au Québec (ADICQ) Disinfectants Fee Setting
8 Caroline Piché Association pour le Développement et l'Innovation en Chimie au Québec (ADICQ) Disinfectants Fee Setting
9 Regulatory Affairs AstraZeneca Canada Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
10 Regulatory Affairs AstraZeneca Canada Pharmaceuticals (Innovator/Biologic Drugs Performance Standards
11 Regulatory Affairs AstraZeneca Canada Pharmaceuticals (Innovator/Biologic Drugs Penalty Provision
12 Biogen Canada Biogen Canada Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
13 Biogen Canada Biogen Canada Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
14 Ron Boch Biogen Canada Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
15 Ron Boch BIOTECanada Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
16 Maggy Mouradian Boehringer Ingelheim Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
17 Maggy Mouradian Boehringer Ingelheim Pharmaceuticals (Innovator/Biologic Drugs Annual Fee Adjustment
18 Maggy Mouradian Boehringer Ingelheim Pharmaceuticals (Innovator/Biologic Drugs Performance Standards
19 Maggy Mouradian Boehringer Ingelheim Pharmaceuticals (Innovator/Biologic Drugs Penalty Provision
20 Maggy Mouradian Boehringer Ingelheim Pharmaceuticals (Innovator/Biologic Drugs Timing of Payment
21 Maggy Mouradian Boehringer Ingelheim Pharmaceuticals (Innovator/Biologic Drugs Specific Fee Line Changes
22 Jean Szkotnicki Canadian Animal Health Institute (CAHI) Veterinary Drugs Fee Setting
23 Jean Szkotnicki Canadian Animal Health Institute (CAHI) Veterinary Drugs Annual Fee Adjustment
24 Jean Szkotnicki Canadian Animal Health Institute (CAHI) Veterinary Drugs Small Business
25 Jean Szkotnicki Canadian Animal Health Institute (CAHI) Veterinary Drugs Performance Standards
26 Jean Szkotnicki Canadian Animal Health Institute (CAHI) Veterinary Drugs Timing of Payment
27 Jean Szkotnicki Canadian Animal Health Institute (CAHI) Veterinary Drugs Specific Fee Line Changes
28 Jean Szkotnicki Canadian Animal Health Institute (CAHI) Veterinary Drugs Mitigation Measures
29 Terri Drover Canadian Association for Pharmacy Distribution Management (CAPDM) Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
30 Terri Drover Canadian Association for Pharmacy Distribution Management (CAPDM) Pharmaceuticals (Innovator/Biologic Drugs Penalty Provision
31 Jim Keon Canadian Generic Pharmaceutical Association (CGPA) Generics Fee Setting
32 Jim Keon Canadian Generic Pharmaceutical Association (CGPA) Generics Small Business
33 Jim Keon Canadian Generic Pharmaceutical Association (CGPA) Generics Mitigation Measures
34 Jim Keon Canadian Generic Pharmaceutical Association (CGPA) Generics Penalty Provision
35 Jim Keon Canadian Generic Pharmaceutical Association (CGPA) Generics Timing of Payment
36 Jim Keon Canadian Generic Pharmaceutical Association (CGPA) Generics Specific Fee Line Changes
37 Wayne A. Burwash Canadian Quarter Horse Association Veterinary Drugs Fee Setting
38 Wayne A. Burwash Canadian Quarter Horse Association Veterinary Drugs Performance Standards
39 Corlena Patterson / Phil Kolodychuk Canadian Sheep Federation Veterinary Drugs Fee Setting
40 Dan Demers Candian Consumer Specialty Prodcuts Association (CCSPA) Disinfectants Fee Setting
41 Dan Demers Candian Consumer Specialty Prodcuts Association (CCSPA) Disinfectants Fee Setting
42 Dianne Azzarello Celgene Inc. Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
43 Dianne Azzarello Celgene Inc. Pharmaceuticals (Innovator/Biologic Drugs Penalty Provision
44 Jeremy McLain Celling Medical Devices Fee Setting
45 Anne Goodbody Centre for Probe Development and Commercialization Radiopharmaceutical Drug Mitigation Measures
46 Don Sawchuk CEVA Animal Health Inc. Veterinary Drugs Fee Setting
47 Steve Leech Chicken Farmers of Canada Veterinary Drugs Fee Setting
48 Norm Morikawa Communications & Power Industries Canada Inc. Medical Devices Annual Fee Adjustment
49 Brian Courtney Conavi Medical Inc Medical Devices Fee Setting
50 Gerry Harrington Consumer Health Products Canada Non-prescription Drugs Fee Setting
51 Richard Parcels Cosmetics Alliance Canada Non-prescription Drugs Annual Fee Adjustment
52 Richard Parcels Cosmetics Alliance Canada Non-prescription Drugs Fee Setting
53 Richard Parcels Cosmetics Alliance Canada Non-prescription Drugs Performance Standards
54 Richard Parcels Cosmetics Alliance Canada Non-prescription Drugs Penalty Provision
55 Cathy J Shupac D&C Mobility Solutions Inc. Non-prescription Drugs Small Business
56 Ana Breivik on behalf of William Chick DSA Consultants on behalf of Chifam Inc. Pharmaceuticals (Innovator/Biologic Drugs Small Business
57 Ana Breivik on behalf of William Chick DSA Consultants on behalf of Chifam Inc. Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
58 Ana Breivik on behalf of RMC Healthcare Inc. DSA Consultants on behalf of RMC Healthcare Inc. Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
59 Ana Breivik on behalf of TERUMO BCT (Canada) Inc. DSA Consultants on behalf of TERUMO BCT (Canada) Inc. Pharmaceuticals (Innovator/Biologic Drugs Small Business
60 Ana Breivik on behalf of Mark Moody DSA Healthcare Imports Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
61 Kristy House Equestrian Canada Veterinary Drugs Fee Setting
62 Kristy House Equestrian Canada Veterinary Drugs Specific Fee Line Changes
63 Kristy House Equestrian Canada Veterinary Drugs Annual Fee Adjustment
64 Kristy House Equestrian Canada Veterinary Drugs Performance Standards
65 Vassilios Christodoulopoulos Euro-Pharm International Canada Inc. Generics Penalty Provision
66 Vassilios Christodoulopoulos Euro-Pharm International Canada Inc. Generics Small Business
67 Vassilios Christodoulopoulos Euro-Pharm International Canada Inc. Generics Timing of Payment
68 Tarik Henein Generic Medical Partners Inc.
Generics Fee Setting
69 John Cockhill Grifols Canada Ltd Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
70 John Cockhill Grifols Canada Ltd Pharmaceuticals (Innovator/Biologic Drugs Annual Fee Adjustment
71 Lisa Chartrand Hoffmann-La Roche Ltd Pharmaceuticals (Innovator/Biologic Drugs Penalty Provision
72 Lisa Chartrand Hoffmann-La Roche Ltd Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
73 Wm.H.L.(Bill) desBarres Horse Welfare Alliance of Canada Veterinary Drugs Fee Setting
74 Gianna Zecchini Inter Medico Medical Devices Fee Setting
75 Margaret Wheler Janssen Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
76 Margaret Wheler Janssen Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Penalty Provision
77 Margaret Wheler Janssen Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Specific Fee Line Changes
78 Margaret Wheler Janssen Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Specific Fee Line Changes
79 Lesia Babiak Johnson & Johnson Family of Companies in Canada Medical Devices Mitigation Measures
80 Lesia Babiak Johnson & Johnson Family of Companies in Canada Medical Devices Specific Fee Line Changes
81 Lesia Babiak Johnson & Johnson Family of Companies in Canada Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
82 Lesia Babiak Johnson & Johnson Family of Companies in Canada Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
83 Lesia Babiak Johnson & Johnson Family of Companies in Canada Pharmaceuticals (Innovator/Biologic Drugs Penalty Provision
84 Lesia Babiak Johnson & Johnson Family of Companies in Canada Non-prescription Drugs Specific Fee Line Changes
85 Rick Jeysman KVR Pharmaceuticals (early clinical stage) Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
86 Robert Crabtree Linde Canada Limited Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
87 Robert Crabtree Linde Canada Limited Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
88 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Fee Setting
89 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Fee Setting
90 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Fee Setting
91 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Annual Fee Adjustment
92 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Mitigation Measures
93 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Performance Standards
94 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Penalty Provision
95 Nancy Abbey MEDEC - Canada's Medical Technology Companies Medical Devices Specific Fee Line Changes
96 Kevin Murray Medline Canada Corp. Medical Devices Fee Setting
97 Aideen Kennedy Medtronic of Canada Medical Devices Mitigation Measures
98 Casey Vander Ploeg National Cattle Feeders' Association Veterinary Drugs Fee Setting
99 Casey Vander Ploeg National Cattle Feeders' Association Veterinary Drugs Annual Fee Adjustment
100 Casey Vander Ploeg National Cattle Feeders' Association Veterinary Drugs Performance Standards
101 Larry Colero Novo Nordisk Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Performance Standards
102 Jenn MacTavish Ontario Sheep Farmers Veterinary Drugs Fee Setting
103 Jenn MacTavish Ontario Sheep Farmers Veterinary Drugs Fee Setting
104 Pfizer Canada Inc. Pfizer Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Mitigation Measures
105 Pfizer Canada Inc. Pfizer Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Timing of Payment
106 Pfizer Canada Inc. Pfizer Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
107 Pfizer Canada Inc. Pfizer Canada Inc. Pharmaceuticals (Innovator/Biologic Drugs Specific Fee Line Changes
108 Pfizer Consumer Healthcare, a division of Pfizer Canada Inc. Pfizer Canada Inc. Non-prescription Drugs Fee Setting
109 Pfizer Consumer Healthcare, a division of Pfizer Canada Inc. Pfizer Canada Inc. Non-prescription Drugs Specific Fee Line Changes
110 Pfizer Consumer Healthcare, a division of Pfizer Canada Inc. Pfizer Canada Inc. Non-prescription Drugs Specific Fee Line Changes
111 Dave Saucier Responsible Distribution Canada Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
112 Nicole Abou Abou Nakad Roche Diagnostics Canada Medical Devices Mitigation Measures
113 Nicole Abou Abou Nakad Roche Diagnostics Canada Medical Devices Mitigation Measures
114 Sani Marc Sani Marc Disinfectants Performance Standards
115 Stephanie Fiorini-Senderovich Sanis Health Inc.
Generics Small Business
116 Jonathan Hare Telemark Veterinary Consulting Veterinary Drugs Fee Setting
117 Angelina Habimana Teva Canada Innovation Pharmaceuticals (Innovator/Biologic Drugs Performance Standards
118 Shan Chaudhuri The Clorox Company of Canada Ltd Disinfectants Fee Setting
119 Shan Chaudhuri The Clorox Company of Canada Ltd Disinfectants Annual Fee Adjustment
120 Shan Chaudhuri The Clorox Company of Canada Ltd Disinfectants Annual Fee Adjustment
121 Malenka Georgiou Turkey Farmers of Canada Veterinary Drugs Fee Setting
122 Malenka Georgiou Turkey Farmers of Canada Veterinary Drugs Performance Standards
123 Ron Boch Vaccine Industry Committee Pharmaceuticals (Innovator/Biologic Drugs Fee Setting
124 Ron Boch Vaccine Industry Committee Pharmaceuticals (Innovator/Biologic Drugs Performance Standards
125 Steve Vivier Vivier Canada Inc. Non-prescription Drugs Fee Setting
126 Enoch Owusu Zimmer Biomet Medical Devices Fee Setting
127 Enoch Owusu Zimmer Biomet Medical Devices Mitigation Measures
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: